首页> 外国专利> BIOMARKER FOR PREDICTING ONSET OF HEREDITARY OVARIAN CANCER AND USE THEREOF

BIOMARKER FOR PREDICTING ONSET OF HEREDITARY OVARIAN CANCER AND USE THEREOF

机译:预测遗传性卵巢癌发病的生物标志物及其用途

摘要

The present invention relates to a biomarker for predicting the onset of hereditary ovarian cancer and a use thereof and, more particularly, to a marker composition for predicting the onset of hereditary ovarian cancer, a composition and kit for predicting the onset of hereditary ovarian cancer, and a method for providing information for predicting the onset of hereditary ovarian cancer. By measuring the mRNA or protein level of a biomarker gene according to the present invention, the onset of hereditary ovarian cancer accompanied by BRCA mutations can be predicted early, and the biomarker can be effectively used as a target for developing a therapeutic agent for hereditary ovarian cancer.
机译:本发明涉及用于预测遗传性卵巢癌的发作的生物标志物及其用途,更具体地说,涉及用于预测遗传性卵巢癌的发作的标志物组合物,用于预测遗传性卵巢癌的发作的组合物和试剂盒,提供用于预测遗传性卵巢癌发作的信息的方法。通过测量根据本发明的生物标志物基因的mRNA或蛋白质水平,可以及早预测伴随BRCA突变的遗传性卵巢癌的发作,并且该生物标志物可以有效地用作开发遗传性卵巢治疗剂的靶标。癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号